Tesamorelin - Beligas Pharmaceuticals

As a GHRH family peptide, tesamorelin stimulates the pituitary to release natural growth hormone, supporting fat metabolism and muscle retention. Approved for treating abdominal fat accumulation in HIV patients, tesamorelin has gained traction in health and fitness settings for its ability to enhance body composition. Daily 2 mg injections result in increased IGF-1 and growth hormone levels, contributing to reduced body fat and moderate muscle gains without exogenous hormone intake. Its structure, designed for enhanced resistance to metabolic breakdown, enables it to deliver sustained growth hormone stimulation while minimizing common GH-related side effects, making it a reliable choice for long-term fat management​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tesamorelin by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.